Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis P Garrison

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2003
The ISPOR Good Practice Modeling Principles--a sensible approach: be transparent, be reasonableLouis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 23, 2022
Paying for Kidneys: Reflections on Welfare Economics, Political Economy, and Market DesignLouis P Garrison
Pharmacoeconomics|September 14, 2010
Regulatory benefit-risk assessment and comparative effectiveness research: strangers, bedfellows or strange bedfellows?Louis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 3, 2009
Editorial: On the benefits of modeling using QALYs for societal resource allocation: the model is the messageLouis P Garrison
The Oncologist|March 19, 2010
Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycleLouis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 2, 2023
Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next?Louis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 16, 2013
Universal health coverage--big thinking versus big dataLouis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?-An OverviewLouis P Garrison
Health Care Financing Review|November 6, 2014
Assessment of the effectiveness of supply-side cost-containment measuresLouis P Garrison
Current Medical Research and Opinion|March 22, 2012
Retrospective outcomes studies for orphan diseases: challenges and opportunitiesPeter Sun, Louis P Garrison
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2003
The ISPOR Good Practice Modeling Principles--a sensible approach: be transparent, be reasonableLouis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 23, 2022
Paying for Kidneys: Reflections on Welfare Economics, Political Economy, and Market DesignLouis P Garrison
Pharmacoeconomics|September 14, 2010
Regulatory benefit-risk assessment and comparative effectiveness research: strangers, bedfellows or strange bedfellows?Louis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 3, 2009
Editorial: On the benefits of modeling using QALYs for societal resource allocation: the model is the messageLouis P Garrison
The Oncologist|March 19, 2010
Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycleLouis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 2, 2023
Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next?Louis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 16, 2013
Universal health coverage--big thinking versus big dataLouis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?-An OverviewLouis P Garrison
Health Care Financing Review|November 6, 2014
Assessment of the effectiveness of supply-side cost-containment measuresLouis P Garrison
Current Medical Research and Opinion|March 22, 2012
Retrospective outcomes studies for orphan diseases: challenges and opportunitiesPeter Sun, Louis P Garrison
Pageof 19